The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “April 2017” and All Insider Sales to “$5,000,000+.”
According to the above filters, the following are trades from company insiders this week.
Sorrento Therapeutics Inc. (SRNE) President and CEO Henry Ji bought 100,000 shares for $2.00 per share on April 19. Since then, the stock price has dropped to $1.70.
It is a biopharmaceutical company that is engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the U.S.
The company has an institutional ownership of 55.38% and insider ownership of 44.96%.
Over the last 12 months, the stock price has dropped by 78% and is now trading with a price-book (P/B) ratio of 1.08. The price is 79.64% below its 52-week high and 9.68% above its 52-week low.
JPMorgan Chase & Co. (JPM) Director James S. Crown bought 11,500 shares for $85.48 per share on April 19. Since then, the stock price has risen to $85.55.
The company is a financial services firm and a banking institution. It offers investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management.
The company has an institutional ownership of 77.09% and insider ownership of 0.54%.
Over the last 12 months, the stock price has risen by 35%, and the price is 8.97% below its 52-week high and 49.96% above its 52-week low.
Pulse Biosciences Inc. (PLSE) 10% owner Robert W. Duggan bought 319,242 shares for $24.45 per share on April 19. Since then, the stock price has risen to $25.42.
It is a development stage medical device company using a novel and proprietary platform technology called nano-pulse electro-signaling (NPES) for biomedical applications.
The company has an institutional ownership of 1.61% and insider ownership of 18.27%.
Over the last 12 months, the stock price has risen by 514% and is now trading with a P/B ratio of 13.46. The price is 28.69% below its 52-week high and 535.73% above its 52-week low.
Oramed Pharmaceuticals Inc. (ORMP) Director Xiaopeng Li bought 52,814 shares for $6.33 per share on April 19. Since then, the stock price has risen to $6.44.
It is a pharmaceutical company engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
The company has an institutional ownership of 1.15% and insider ownership of 27.22%.
Over the last 12 months, the stock price has dropped by 31% and is now trading with a P/B ratio of 3.92. The price is 39.77% below its 52-week high and 11.05% above its 52-week low.
Most important sales of the week
Jabil Circuit Inc. (JBL) Director Thomas A. Sansone sold 15,645 shares for $29.25 per share on April 12. Since then, the stock price has risen to $29.37.
The company together with its subsidiaries is a provider of electronic manufacturing services and solutions. It provides electronic design, production and product management services to companies in aerospace and defense and automotive.
The company has an institutional ownership of 94.24% and insider ownership of 6.26%.
Over the last 12 months, the stock price has risen by 64% and is now trading with a P/B ratio of 2.21. The price is 0.24% below its 52-week high and 75.03% above its 52-week low.
Salesforce.com Inc. (CRM) Chairman of the Board and CEO Marc Benioff and President, Vice Chairman and Chief Operating Officer Keith Block sold 30,000 shares for $83.93 per share on April 19 and 20. Since then, the stock price has risen to $84.05.
The company provides enterprise cloud computing solutions, offering social and mobile cloud apps and platform services as well as professional services to facilitate the adoption of its solutions.
The company has an institutional ownership of 85.26% and insider ownership of 5.53%.
Over the last 12 months, the stock price has risen by 9% and is now trading with a P/B ratio of 7.93. The price is 2.74% below its 52-week high and 26.52% above its 52-week low.
Alphabet Inc. Class CÂ (GOOG) Google Inc. CEO Sundar Pichai sold 4,000 shares for $841.50 per share on April 19. Since then, the stock price has declined to $838.21.
Alphabet through its subsidiary Google is engaged in improving the ways people connect with information and products including Search, Android, YouTube, Apps, Maps and Ads. It also produces internet-connected home devices and provides internet services.
The company has an institutional ownership of 34.23% and insider ownership of 0.36%.
Over the last 12 months, the stock price has risen by 11% and is now trading with a P/B ratio of 4.26. The price is 1.79% below its 52-week high and 26.37% above its 52-week low.
Netflix Inc. (NFLX) Director Richard N. Barton sold 2,000 shares for $145.38 per share on April 19. Since then, the stock price has dropped to $139.76.
The company operates as an internet television network providing TV shows and movies that include original series, documentaries and feature films.
The company has an institutional ownership of 88.17% and insider ownership of 0.15%.
Over the last 12 months, the stock price has risen by 11% and is now trading with a P/B ratio of 4.26. The price is 5.75% below its 52-week high and 65.40% above its 52-week low.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Start a free seven-day trial of Premium Membership to GuruFocus.
